Get started
3D GLOBAL BIOTECH INC33

3D GLOBAL BIOTECH INC

49.15TWDR
+1.90+4.02%
At close at Aug 1, 06:11 GMT
TWD
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

6808 fundamentals

Key facts

Market capitalization‪3.78 B‬TWD
Dividend yield (indicated)1.08%
Price to earnings Ratio (TTM)36.47
Basic EPS (TTM)1.33TWD
Founded2014
Employees (FY)—
CEOKeng Liang Ou
Website3dglobalbiotech.com.tw
About

3D Global Biotech, Inc. develops and distributes biotechnology products. It produces artificial bone substitutes, granial and maxillofacial products, implants, biotechnology dressings, biotechnology inks, ophthalmic products, and other products. The company was founded on December 26, 2014 and is headquartered in New Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪3.78 B‬‬
Price to earning ratio (P/E)
36.47x
Price to sales ratio (P/S)
12.56x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
36.47x
Price to sales ratio (P/S)
12.56x
Valuation ratios
‪0.00‬
‪30.00‬
‪60.00‬
‪90.00‬
‪120.00‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪15.00‬
‪30.00‬
‪45.00‬
‪60.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−480%‬
‪−320%‬
‪−160%‬
‪0%‬
‪160%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−80.00 M‬‬
‪0.00‬
‪‪80.00 M‬‬
‪‪160.00 M‬‬
‪‪240.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
‪‪240.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
‪‪240.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Medical Equipment
Contract Development and Manufacturing
Technology License
By country
Period: 2024
Taiwan
China
United States

Dividends

Dividend yield, history and sustainability

Dividend summary
39.72%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
1.08%
Last payment
0.53
Last ex-date
Jul 7, 2025
Last pay date
Jul 30, 2025
Dividend history
‪0.0%‬
‪0.2%‬
‪0.4%‬
‪0.6%‬
‪0.8%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.15‬
‪0.30‬
‪0.45‬
‪0.60‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−30.00 M‬‬
‪0.00‬
‪‪30.00 M‬‬
‪‪60.00 M‬‬
‪‪90.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
‪‪840.00 M‬‬
Assets
Liabilities